Regional health authorities across the world are developing an increased appetite for electronic product information, which could be a much more efficient and patient-friendly way of conveying the latest manufacturing details and safety recommendations. But how ready are life sciences firms to deliver regulated product information in this way? Agnes Cwienczek at Amplexor assesses the broader potential business case and suggests how companies might determine their readiness for delivering reliable electronic product information – and begin to scope the work ahead.